Intro

This chapter explores the substantial $7.4 billion settlement announcement from Purdue Pharma, tied to its role in the opioid crisis through aggressive marketing of OxyContin. It highlights the implications for the Sackler family and addresses the broader impact of addiction and overdose deaths on communities across the U.S.